You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial

Article metrics

Article menu

Download PDFPDF

Oral Presentations
From classics to new: synthetic DMARDs in RA
OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017803
Jul 20172001
Aug 20171404
Sep 20171002
Oct 20171203
Nov 2017800
Dec 20171400
Jan 20181202
Feb 2018600
Mar 20182802
Apr 20181800
May 2018400
Jun 2018200
Jul 2018602
Aug 2018601
Sep 2018803
Oct 2018202
Nov 2018402
Dec 2018602
Jan 2019601
Feb 20191101
Mar 2019602
Apr 2019002
May 2019204
Jun 2019504
Jul 2019302
Aug 2019802
Sep 2019201
Oct 2019201
Nov 2019003
Jan 2020001
Feb 2020201
Mar 2020001
Apr 2020102
May 2020902
Jun 2020900
Jul 20201605
Aug 2020402
Sep 20201201
Oct 20207020
Nov 2020201
Dec 2020401
Jan 2021001
Feb 2021003
Mar 2021808
Apr 2021201
May 2021301
Jun 2021001
Aug 2021001
Sep 2021001
Oct 20218017
Nov 20214012
Dec 20211003
Feb 2022600
Mar 2022402
Apr 2022200
May 20221107
Jun 20221004
Jul 20221000
Aug 20221002
Sep 2022207
Oct 2022604
Nov 2022204
Dec 2022802
Jan 2023401
Mar 2023800
Apr 2023200
May 2023602
Jun 2023600
Jul 2023203
Aug 2023203
Nov 2023701
Dec 20231201
Jan 2024203
Feb 2024401
Mar 20242022
Total4620207